News & Events
Sept. 19, 2024:
Therataxis’ FDA-cleared drug delivery simulation software Molecular Flow Systems (MFS) has now been sold to Precision Neuromed, Inc. For further information, please contact info@precisionneuromed.com.
 |
 |
 |
|||||
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
Therataxis’ FDA-cleared drug delivery simulation software Molecular Flow Systems (MFS) has now been sold to Precision Neuromed, Inc. For further information, please contact info@precisionneuromed.com.